Major Depressive Disorder (MDD) Clinical Trials in Atlanta, Georgia

3 studies are recruiting for major depressive disorder (mdd) in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

    This is a randomized, parallel-group, double-blind, placebo-controlled, monotherapy study to evaluate the efficacy, safety, and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD), with or without anxious distress.

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Seaport Investigator Site, Atlanta, Georgia
    Locations
    61 in total
    Run by
    Seaport Therapeutics

    See if you can join NCT07065240 on ClinicalTrials.gov

  2. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

    The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD. For more information about the EMBRACE study, including participating study locations, and to register your interest in learning more …

    Stage
    Phase 3
    Ages
    18 to 85
    Site
    Emory University Dept of Psychiatry and Behavioral Studies, Atlanta, Georgia
    Locations
    69 in total
    Run by
    Cybin IRL Limited

    See if you can join NCT06793397 on ClinicalTrials.gov

  3. A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

    The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Draig Clinical Site, Atlanta, Georgia
    Locations
    43 in total
    Run by
    Draig Therapeutics Ltd

    See if you can join NCT07300969 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.